Dual-Target Nectin-4/HER2 CAR-NK Cells

· Beijing Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual-Target Nectin-4/HER2 CAR-NK Cells, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma [Phase 1]